Retraction: Exogenous t-PA administration increases hippocampal mature BDNF levels. Plasmin-or NMDA-dependent mechanism? (PLoS ONE (2014) 9:3 (e92416) DOI: 10.1371/journal.pone.0092416);Exogenous t-PA administration increases hippocampal mature BDNF levels. Plasmin- Or NMDA-dependent mechanism?

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Rodier, Marion ^a,b,c   Prigent Tessier, Anne ^a,b   Béjot, Yannick ^c,d   Jacquin, Agnès ^c,d   Mossiat, Claude ^a,b   Marie, Christine ^a,b   Garnier, Philippe ^a,b  

^a Université de Bourgogne Franche Comté   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c DIJON UNIVERSITY HOSPITAL   (France)

^d EA 4184   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLASMIN; PLASMINOGEN; TRANEXAMIC ACID; BRAIN-DERIVED NEUROTROPHIC FACTOR PRECURSOR; DIZOCILPINE MALEATE; N METHYLASPARTIC ACID; PROTEIN PRECURSOR; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HIPPOCAMPUS; MALE; MOLECULAR MECHANICS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN METABOLISM; RAT; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; METABOLISM; WISTAR RAT;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DIZOCILPINE MALEATE; FIBRINOLYSIN; HIPPOCAMPUS; MALE; N-METHYLASPARTATE; PROTEIN PRECURSORS; RATS, WISTAR; RECEPTOR, TRKB; TISSUE PLASMINOGEN ACTIVATOR; TRANEXAMIC ACID;

EID: 84899872501     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0255763     Document Type: Erratum

References (54)

1. Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S (2010) Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol 70: 271-288.
2. Park H, Poo MM. (2013) Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci 14: 7-23.
3. Horch HW, Katz LC (2002) BDNF release from single cells elicits local dendritic growth in nearby neurons. Nat Neurosci 5: 1177-1184. (Pubitemid 35247177)
4. Tanaka J, Horiike Y, Matsuzaki M, Miyazaki T, Ellis-Davies GC, et al. (2008) Protein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines. Science 319: 1683-1687. (Pubitemid 351432509)
5. McAllister AK, Lo DC, Katz LC (1995) Neurotrophins regulate dendritic growth in developing visual cortex. Neuron 15: 791-803.
6. Patterson SL, Abel T, Deuel TA, Martin KC, Rose JC, et al. (1996) Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 16: 1137-1145. (Pubitemid 26227235)
7. Waterhouse EG, Xu B (2009) New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol Cell Neurosci 42: 81-89.
8. Cowansage KK, LeDoux JE, Monfils MH (2010) Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity. Curr Mol Pharmacol 3: 12-29.
9. Mattson MP (2008) Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann N Y Acad Sci 1144: 97-112.
10. Lipsky RH, Marini AM (2007) Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann N Y Acad Sci 1122: 130-143. (Pubitemid 350249544)
11. Lu B, Pang PT, Woo NH (2005) The yin and yang of neurotrophin action. Nat Rev Neurosci 6: 603-614. (Pubitemid 41059335)
12. Barker PA (2009) Whither proBDNF? Nat Neurosci 12: 105-106.
13. Greenberg ME, Xu B, Lu B, Hempstead BL (2009) New insights in the biology of BDNF synthesis and release: implications in CNS function. J Neurosci 29: 12764-12767.
14. Samson AL, Medcalf RL (2006) Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity. Neuron 50: 673-678. (Pubitemid 44218660)
15. Yepes M, Roussel BD, Ali C, Vivien D (2009) Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Trends Neurosci 32: 48-55.
16. Huang YY, Bach ME, Lipp HP, Zhuo M, Wolfer DP, et al. (1996) Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways. Proc Natl Acad Sci U S A 93: 8699-8704. (Pubitemid 26269623)
17. Madani R, Hulo S, Toni N, Madani H, Steimer T, et al. (1999) Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice. EMBO J 18: 3007-3012. (Pubitemid 29255609)
18. Zhuo M, Holtzman DM, Li Y, Osaka H, DeMaro J, et al. (2000) Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. J Neurosci 20: 542-549. (Pubitemid 30225556)
19. Chen ZL, Strickland S (1997) Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91: 917-925.
20. Pang PT, Teng HK, Zaitsev E, Woo NT, Sakata K, et al. (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306: 487-491. (Pubitemid 39372449)
21. Nagappan G, Zaitsev E, Senatorov VV Jr, Yang J, Hempstead BL, et al. (2009) Control of extracellular cleavage of ProBDNF by high frequency neuronal activity. Proc Natl Acad Sci U S A 106: 1267-1272.
22. Anderson CM, Norquist BA, Vesce S, Nicholls DG, Soine WH, et al. (2002) Barbiturates induce mitochondrial depolarization and potentiate excitotoxic neuronal death. J Neurosci 22: 9203-9209. (Pubitemid 35356163)
23. Kotermanski SE, Johnson JW, Thiels E (2013) Comparison of behavioral effects of the NMDA receptor channel blockers memantine and ketamine in rats. Pharmacol Biochem Behav 109: 67-76.
24. Quirie A, Hervieu M, Garnier P, Demougeot C, Mossiat C, et al. (2012) Comparative effect of treadmill exercise on mature BDNF production in control versus stroke rats. PLoS One 7: e44218.
25. Madinier A, Bertrand N, Rodier M, Quirie A, Mossiat C, et al. (2013) Ipsilateral versus contralateral spontaneous post-stroke neuroplastic changes: involvement of BDNF? Neuroscience 231: 169-181.
26. Binder DK, Scharfman HE (2004) Brain-derived neurotrophic factor. Growth Factors 22: 123-131. (Pubitemid 39377904)
27. Autry AE, Monteggia LM (2012) Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 64: 238-258.
28. Lee R, Kermani P, Teng KK, Hempstead BL (2001) Regulation of cell survival by secreted proneurotrophins. Science 294: 1945-1948. (Pubitemid 33101595)
29. Horii-Hayashi N, Yoshikawa M, Matsusue Y, Ishizaka S, Nishi M, et al. (2011) Environmental stimulation changes tissue-type plasminogen activator activity in the adult mouse hippocampus. Neurochem Int 58: 1-4.
30. Obiang P, Maubert E, Bardou I, Nicole O, Launay S, et al. (2011) Enriched housing reverses age-associated impairment of cognitive functions and tPA-dependent maturation of BDNF. Neurobiol Learn Mem 96: 121-129.
31. Segawa M, Morinobu S, Matsumoto T, Fuchikami M, Yamawaki S (2013) Electroconvulsive seizure, but not imipramine, rapidly up-regulates pro-BDNF and t-PA, leading to mature BDNF production, in the rat hippocampus. Int J Neuropsychopharmacol 16: 339-350.
32. Ding Q, Ying Z, Gomez-Pinilla F (2011) Exercise influences hippocampal plasticity by modulating brain-derived neurotrophic factor processing. Neuroscience 192: 773-780.
33. Yeh CM, Huang CC, Hsu KS (2012) Prenatal stress alters hippocampal synaptic plasticity in young rat offspring through preventing the proteolytic conversion of pro-brain-derived neurotrophic factor (BDNF) to mature BDNF. J Physiol 590: 991-1010.
34. Benchenane K, Berezowski V, Ali C, Fernandez-Monreal M, Lopez-Atalaya JP, et al. (2005) Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis. Circulation 111: 2241-2249. (Pubitemid 40632441)
35. Vivien D, Buisson A (2000) Serine protease inhibitors: novel therapeutic targets for stroke? J Cereb Blood Flow Metab 20: 755-764. (Pubitemid 30317049)
36. Sartori CR, Vieira AS, Ferrari EM, Langone F, Tongiorgi E, et al. (2011) The antidepressive effect of the physical exercise correlates with increased levels of mature BDNF, and proBDNF proteolytic cleavage-related genes, p11 and tPA. Neuroscience 180: 9-18.
37. Furtmuller R, Schlag MG, Berger M, Hopf R, Huck S, et al. (2002) Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gammaaminobutyric acid(A) receptor antagonistic effect. J Pharmacol Exp Ther 301: 168-173. (Pubitemid 34256345)
38. Menoud PA, Sappino N, Boudal-Khoshbeen M, Vassalli JD, Sappino AP (1996) The kidney is a major site of alpha(2)-antiplasmin production. J Clin Invest 97: 2478-2484. (Pubitemid 26187334)
39. Kawashita E, Kanno Y, Asayama H, Okada K, Ueshima S, et al. (2013) Involvement of alpha2-antiplasmin in dendritic growth of hippocampal neurons. J Neurochem 126: 58-69.
40. Taniguchi Y, Inoue N, Morita S, Nikaido Y, Nakashima T, et al. (2011) Localization of plasminogen in mouse hippocampus, cerebral cortex, and hypothalamus. Cell Tissue Res 343: 303-317.
41. Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, et al. (2001) The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 7: 59-64.
42. Benchenane K, Castel H, Boulouard M, Bluthe R, Fernandez-Monreal M, et al. (2007) Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory. J Cell Sci 120: 578-585. (Pubitemid 46437892)
43. Pawlak R, Melchor JP, Matys T, Skrzypiec AE, Strickland S (2005) Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors. Proc Natl Acad Sci U S A 102: 443-448. (Pubitemid 40116786)
44. Obiang P, Macrez R, Jullienne A, Bertrand T, Lesept F, et al. (2012) GluN2D subunit-containing NMDA receptors control tissue plasminogen activator-mediated spatial memory. J Neurosci 32: 12726-12734.
45. Martin AM, Kuhlmann C, Trossbach S, Jaeger S, Waldron E, et al. (2008) The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-type plasminogen activator-mediated activation of N-methyl-D-aspartate receptors. J Biol Chem 283: 12004-12013.
46. Vaynman S, Ying Z, Gomez-Pinilla F (2003) Interplay between brain-derived neurotrophic factor and signal transduction modulators in the regulation of the effects of exercise on synaptic-plasticity. Neuroscience 122: 647-657. (Pubitemid 37410286)
47. Kolarow R, Brigadski T, Lessmann V (2007) Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium calmodulin kinase II signaling and proceeds via delayed fusion pore opening. J Neurosci 27: 10350-10364. (Pubitemid 47501996)
48. Baron A, Montagne A, Casse F, Launay S, Maubert E, et al. (2010) NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity. Cell Death Differ 17: 860-871.
49. Paoletti P, Bellone C, Zhou Q (2013) NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 14: 383-400.
50. Echeverry R, Wu J, Haile WB, Guzman J, Yepes M (2010) Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. J Clin Invest 120: 2194-2205.
51. Liot G, Benchenane K, Leveille F, Lopez-Atalaya JP, Fernandez-Monreal M, et al. (2004) 2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo. J Cereb Blood Flow Metab 24: 1153-1159. (Pubitemid 39332154)
52. Reichardt LF (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 361: 1545-1564.
53. Aas M, Haukvik UK, Djurovic S, Bergmann O, Athanasiu L, et al. (2013) BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses. Prog Neuropsychopharmacol Biol Psychiatry 46: 181-188.
54. Parcq J, Bertrand T, Montagne A, Baron AF, Macrez R, et al. (2012) Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicity. Cell Death Differ 19: 1983-1991.